Medscape

Durable Patency With Superficial Femoral Artery Stenting

November 21, 2011 (New York, New York) — Three-year follow-up of the RESILIENT trial has shown that the LifeStent vascular stent (Bard Peripheral Vascular) leads to durable benefits and clinical ...
Healio

Peripheral stent beneficial in common femoral artery stenosis at 2 years

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio LAS VEGAS — A repuncturable vascular ...
Healio

Stenting bests surgery for perioperative morbidity, mortality in de novo common femoral artery stenosis

Endovascular therapy, compared with surgery, was associated with significantly lower perioperative morbidity and mortality in patients with de novo atherosclerotic lesions of the common femoral artery ...
TCTMD

Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study

New Clinical Data Presented for First Time at Medical Meetings in U.S. and Europe Show Durable Vessel Patency in Treating Atherosclerotic Lesions of Superficial Femoral Artery MINNEAPOLIS –– ...
FierceBiotech

J&J's Cordis touts stent for femoral artery disease

Cordis, a unit of Johnson & Johnson ($JNJ) is seeking an expanded indication for its SMART self-expanding stent, and the device performed well in patients with ...
Forbes

FDA Approves Zilver PTX Drug-Eluting Stent For Peripheral Arterial Disease

The FDA today approved Cook Medical's Zilver PTX stent. It is the first drug-eluting stent (DES) approved for the treatment of peripheral arterial disease (PAD) in the superficial femoral and proximal ...
TCTMD

Common-Femoral Lesions: LINC 2020 Experts Hash Out the Best PAD Treatment

LEIPZIG, GERMANY—What’s the best course of corrective action for obstructive lesions of the common femoral artery (CFA) caused by PAD? At LINC 2020, two experts took to the main stage to debate this ...

BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...
The Financial Express

Boston Scientific’s stent approved for peripheral artery disease

Medical device maker Boston Scientific Inc said its stent to prevent the blocking of arteries in the legs was approved in the United States, four years after the device was recalled outside the ...
Endovascular Today

BD Completes Enrollment of Iliac Cohort in AGILITY IDE Study of Revello Covered Stent

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...
Medscape

TCAR Direct Access Carotid Stenting Lowers Stroke Risk

A new approach to carotid stenting, in which the carotid artery is accessed directly instead of by use of a catheter that is guided through the circulation from the groin, has shown lower rates of ...